APA (7th ed.) Citation

DC, J., EJ, M., P, M., T, F., J, M., JS, R., . . . J, L. (2005). Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. Journal of Infectious Diseases, 192(12), 2129. https://doi.org/10.1086/498163

Chicago Style (17th ed.) Citation

DC, Johnson, et al. "Safety and Immunogenicity of an HIV-1 Recombinant Canarypox Vaccine in Newborns and Infants of HIV-1-infected Women." Journal of Infectious Diseases 192, no. 12 (2005): 2129. https://doi.org/10.1086/498163.

MLA (9th ed.) Citation

DC, Johnson, et al. "Safety and Immunogenicity of an HIV-1 Recombinant Canarypox Vaccine in Newborns and Infants of HIV-1-infected Women." Journal of Infectious Diseases, vol. 192, no. 12, 2005, p. 2129, https://doi.org/10.1086/498163.